Quote | Algernon Pharmaceuticals Inc - Class A (OTCMKTS:AGNPF)
Last: | $0.0791 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0791 |
High: | $0 |
Low: | $0 |
Volume: | 8 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Algernon Pharmaceuticals Inc - Class A (OTCMKTS:AGNPF)
VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it ha...
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its...
Message Board Posts | Algernon Pharmaceuticals Inc - Class A (OTCMKTS:AGNPF)
Subject | By | Source | When |
---|---|---|---|
The good Old Days | shell3 | investorshub | 05/01/2023 7:33:00 PM |
Great possible dip and longer term thoughts. Math, | tcm55 | investorshub | 05/01/2023 7:24:56 PM |
As always, great analysis, agree with all. | GVX808 | investorshub | 04/29/2023 5:58:30 AM |
After a couple Reverses which works out to | shell3 | investorshub | 04/28/2023 11:53:37 PM |
Cool If you cant raise money another way, | GVX808 | investorshub | 04/28/2023 5:46:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Algernon Pharmaceuticals Inc - Class A Company Name:
AGNPF Stock Symbol:
OTCMKTS Market:
Algernon Pharmaceuticals Inc - Class A Website:
VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it ha...
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its...
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to invite investors and other interested parties to participate in an upcoming speci...